Dec 20, 2024
To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - HDFC Pharma and Healthcare Fund - Regular (G) | 3.47 | 25.79 | 51.93 | 0 |
| Benchmark - S&P BSE Healthcare TRI | -1.88 | 10.85 | 37 | 11.94 |
| Category Average - BEST EQUITY PERFORMERS | 2.3 | 3.1 | 25.86 | 19.51 |
| Category Rank | 5/8 | 6/8 | 6/8 | 7/8 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Nippon India US Equity Opportunities Fund (G) | 33.9996 | 0.82 | 21.03 | 8.89 | 14.14 | 719.18 | 2.39 | 100.00 | invest |
| Nippon India US Equity Opportunities Fund (IDCW) | 33.9996 | 0.82 | 21.03 | 8.89 | 14.14 | 719.18 | 2.39 | 100.00 | invest |
| SBI Healthcare Opportunities Fund (G) | 429.2021 | 0.37 | 42.39 | 25.37 | 29.37 | 3,459.68 | 1.95 | 5,000.00 | invest |
| SBI Healthcare Opportunities Fund (IDCW) | 270.3752 | 0.37 | 42.39 | 25.37 | 29.37 | 3,459.68 | 1.95 | 5,000.00 | invest |
| Quant Teck Fund - Regular (G) | 13.3489 | -3.00 | 27.40 | 0.00 | 0.00 | 442.10 | 2.39 | 5,000.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Nov 30, 2024 | 196.81 | 13.48 | 1.56 |
|
| Equity-Divi`s Lab. | Nov 30, 2024 | 114.57 | 7.85 | 4.81 |
|
| Equity-Cipla | Nov 30, 2024 | 113.10 | 7.75 | 0.17 |
|
| Equity-Lupin | Nov 30, 2024 | 84.72 | 5.80 | -1.99 |
|
| Equity-Gland Pharma | Nov 30, 2024 | 58.27 | 3.99 | 5.26 |
|
| Equity-Ipca Labs. | Nov 30, 2024 | 54.71 | 3.75 | -2.91 |
|
| Equity-Aster DM Health. | Nov 30, 2024 | 52.06 | 3.57 | 16.57 |
|
| Equity-Vijaya Diagnost. | Nov 30, 2024 | 51.63 | 3.54 | 22.62 |
|
| Equity-ERIS Lifescience | Nov 30, 2024 | 49.28 | 3.38 | 8.84 |
|
| Equity-Glenmark Pharma. | Nov 30, 2024 | 49.16 | 3.37 | 21.72 |
|
HDFC Mutual Fund has announced 19 December 2024 as the record date for decl...
HDFC Mutual Fund has announced 25 November 2024 as the record date for decl...
HDFC Mutual Fund has announced 21 November 2024 as the record date for decl...
HDFC Mutual Fund has announced 21 November 2024 as the record date for decl...
HDFC Mutual Fund has announced change in scheme name under the following sc...
HDFC Mutual Fund has announced 25 October 2024 as the record date for decla...
| AMC Name | : | HDFC Mutual Fund |
| Fund Name | : | HDFC Pharma and Healthcare Fund - Regular (G) |
| Contact Persone | : | Nikhil Mathur |
| Registered Address | : | HDFC House, 2nd Flr, H.T.Parekh Marg,165-166, Backbay Reclamation,Churchgate, Mumbai - 400 020. |
| Telephone No | : | 022 - 6631 6333 |
| Fax No. | : | 022 - 22821144 |
| : | hello@hdfcfund.com | |
| Website | : | www.hdfcfund.com |
Top Mutual Funds
